| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Executive Officer
1 company
Alan J Tuchman last filed a Form 4 in June 2025, as Chief Medical Officer at TAOX. Alan J Tuchman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,909 shares of TAOX. The TAOX filings lean toward selling, a net 27,000 shares.
Alan J Tuchman has 5 Form 4 filings on record from July 2021 to June 2025, all as Chief Medical Officer at TAO Synergies (TAOX), 2021–2025.
The 6 reported transactions were 2 stock awards, 2 option or other derivative awards, 1 tax withholding and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $32K.
The only open-market sale was 27,000 shares of TAOX at an average $1.17 on December 16, 2022, about $32K. Twelve months later TAOX was down 77%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | TAOX Tao Synergies Inc. | Chief Executive Officer | Sell | 27,000 | $1.17 | $31,641.30 | -45.0% | -29.9% | -77.2% |